Change of Name

RNS Number : 8618I
Ferrex PLC
11 December 2015
 

Ferrex plc / Index: AIM / Epic: FRX / Sector: Mining

11 December 2015

Ferrex Plc

Change of Name

 

The directors of Ferrex Plc ('the Company'), the AIM quoted resource development company, are pleased to announce that the Company has changed its name to Keras Resources Plc.

 

The existing ordinary shares of 0.1p each admitted to trading on AIM will be renamed to Keras Resources Plc with stock code KRS with effect from Monday 14 December 2015.

 

**ENDS**

 

For further information visit www.ferrexplc.com or contact the following: 

Dave Reeves

Keras Resources Plc

dave@kerasplc.com

+44 (0)20 7220 0500

Nominated Adviser



William Vandyk/David Hignell

Northland Capital Partners Limited

+44 (0) 20 7382 1100

Broker

Elliot Hance/Jonathon Belliss

Beaufort Securities Limited

+44(0)20 7382 8415

Financial PR



Felicity Winkles/ Elisabeth Cowell

St Brides Partners Limited

+44 (0) 20 7236 1177

 

 

Notes

Keras Resources Plc ("Keras") is an AIM quoted, resource development company.  Keras is focussed on advancing lowest quartile, low capex deposits which benefit from proximal established infrastructure up the development curve and into production.  Keras plans to commence production at its Australian Gold Project in Q2 2016 and then use this cashflow to develop the Nayega Manganese Project within nine months of securing the mining permit for the Project.  

 

At Nayega, Keras has concluded a Bankable Feasibility Study and expects award of the mining permit in the near future.  The Bankable Feasibility Study indicates that Nayega could produce 250,000 tonnes per year of manganese concentrate at 38%.   On grant of the mining permit Keras will focus on bringing the mine into production as soon as possible.  

 

Keras also holds iron ore and manganese projects in Gabon and South Africa and is actively assessing ways to realise value from these assets.

 

Keras has 1,193,794,390 ordinary shares of 0.1p each in issue. The Directors have subscribed for and purchased approximately 25.5% of the issued share capital of Keras and are thus aligned with shareholders' interests.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CANLLFVEFFLLLIE
UK 100

Latest directors dealings